chloramphenicol/colistimethate sodium/rolitetracycline

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug Namechloramphenicol/colistimethate sodium/rolitetracycline

Drug Alias NameColbiocin

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Lipopeptide antibiotics

Mechanisms of Action50S ribosomal subunit inhibitorsPurinergic receptor P2Y12 antagonists30S ribosomal subunit inhibitors

Targets50S ribosomal subunitPurinergic receptor P2Y1230S ribosomal subunit

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryRussian Federation

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsYes Chloramphenicol Colistimethate sodium Rolitetracycline

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesSIFI SpA

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A